Clinical Trial Update: Safety and Efficacy of a 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Trauma Patients [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety and efficacy of a 6% hydroxyethyl starch solution compared to an electrolyte solution in trauma patients with hypovolemia due to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypovolemia Due to Acute Blood Loss

Drugs mentioned

• 6% hydroxyethyl starch solution

Snippet

Sponsor: Fresenius Kabi | Conditions: Hypovolemia Due to Acute Blood Loss | Phase 4 | Status: COMPLETED